By Dr. Shipra Gandhi Roswell Park Comprehensive Cancer Center Endocrine therapy is the mainstay of the management of hormone receptor (HR) positive breast cancer. Until now, fulvestrant remained the only selective
Read about the Binaytara Foundation October Conferences!
More
Zhu Shares About Her Experience Volunteering at the Binaytara Foundation Meet June Zhu, one of our amazing volunteers! She has volunteered at two of our conferences in Salt Lake City and she
More
The Foundation Participated in Hackathon by Microsoft to Create Prototype The Binaytara Foundation teamed up with employees of Microsoft to work on the development of our Cancer Crush app in this year’s
More
Binaytara Foundation has announced Dr. Umang Swami as Editor-in-Chief of the International Journal of Cancer Care & Delivery
More
Dr. Rubina Suwal of the Binaytara Foundation Cancer Center performs successful oral cancer surgery for patient in local community
More
The Binaytara Foundation hosted two conferences in September 2022
More
Fall brings five conferences to the Pacific Northwest and Utah The Binaytara Foundation has organized five conferences in September and October, located in three states, Washington, Oregon, and Utah. Most of the
More
ASCO Direct™ Highlights Oncology conference held in Seattle to present and discuss the latest findings in cancer research and treatments The Binaytara Foundation held the ASCO Direct™ Highlights: 2022 Official Annual Meeting
More
The Binaytara Foundation (BTF) is pleased to welcome Dr. Sri Tantravahi as the new Co-Chair of the BTF Education Academy. Dr. Tantravahi will work closely with Dr. Sid Yadav, who will also
More
As part of our series of interviews with the 2022 Binaytara Foundation (BTF) award winners who are improving access to cancer care, today we talk with Dr. Bhawna Sirohi, winner of the
More